1. Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
   Zhonghe Zhao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
   Jiajun Wu et al, 2022, Cancers CrossRef
3. Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
   Liang Chen et al, 2021, Mediators of Inflammation CrossRef
4. The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis
   Chong Shen et al, 2024, Heliyon CrossRef
5. Natural Agents-Mediated Targeting of Histone Deacetylases
   Ammad Ahmad Farooqi et al, 2018, Archivum Immunologiae et Therapiae Experimentalis CrossRef
6. The Inhibition of Cell Growth Through the EGFR/ERK/MMP-2 Pathway Induced by Ampelopsin in the Human Malignant Melanoma A375 Cell Line
   Fan Yang et al, 2020, Natural Product Communications CrossRef
7. Ampelopsin targets in cellular processes of cancer: Recent trends and advances
   Hardeep Singh Tuli et al, 2022, Toxicology Reports CrossRef
8. Involvement of F-BOX proteins in progression and development of human malignancies
   Shahab Uddin et al, 2016, Seminars in Cancer Biology CrossRef
9. Ubiquitin‐independent, Proteasome‐mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system
   Yihui Ma et al, 2019, IUBMB Life CrossRef
10. Ampelopsin‑sodium induces apoptosis in human lung adenocarcinoma cell lines by promoting tubulin polymerization in�vitro
    Lijuan Zhu et al, 2019, Oncology Letters CrossRef
11. Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
    Yasir Qasim Almajidi et al, 2023, Environmental Research CrossRef